<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Oncologo Calabrò: &#8220;Con nivolumab nuove prospettive per cancro uroteliale&#8221; &#8216;Immunoterapia efficace in fase adiuvante e metastatica&#8217;	</title>
	<atom:link href="https://www.lafrecciaweb.it/2026/05/04/oncologo-calabro-con-nivolumab-nuove-prospettive-per-cancro-uroteliale-immunoterapia-efficace-in-fase-adiuvante-e-metastatica-2/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.lafrecciaweb.it/2026/05/04/oncologo-calabro-con-nivolumab-nuove-prospettive-per-cancro-uroteliale-immunoterapia-efficace-in-fase-adiuvante-e-metastatica-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=oncologo-calabro-con-nivolumab-nuove-prospettive-per-cancro-uroteliale-immunoterapia-efficace-in-fase-adiuvante-e-metastatica-2</link>
	<description>la velocità dell&#039;informazione</description>
	<lastBuildDate>Mon, 04 May 2026 15:12:00 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
